C Gaiteri, S Mostafavi, CJ Honey… - Nature reviews …, 2016 - pubmed.ncbi.nlm.nih.gov
Genetic studies in late-onset Alzheimer disease (LOAD) are aimed at identifying core disease mechanisms and providing potential biomarkers and drug candidates to improve …
C Gaiteri, S Mostafavi, C Honey… - Nature reviews …, 2016 - ncbi.nlm.nih.gov
Genetic studies in late-onset Alzheimer disease (LOAD) are aimed at identifying core disease mechanisms and providing potential biomarkers and drug candidates to improve …
C Gaiteri, S Mostafavi, CJ Honey… - Nature Reviews …, 2016 - go.gale.com
Genetic studies in late-onset Alzheimer disease (LOAD) are aimed at identifying core disease mechanisms and providing potential biomarkers and drug candidates to improve …
C Gaiteri, S Mostafavi, CJ Honey, PL De Jager… - 2016 - honeylab.org
Genetic studies in late-onset Alzheimer disease (LOAD) are aimed at identifying core disease mechanisms and providing potential biomarkers and drug candidates to improve …
C Gaiteri, S Mostafavi, CJ Honey… - Nature reviews …, 2016 - europepmc.org
Genetic studies in late-onset Alzheimer disease (LOAD) are aimed at identifying core disease mechanisms and providing potential biomarkers and drug candidates to improve …
C Gaiteri, S Mostafavi, CJ Honey… - Nature Reviews …, 2016 - search.proquest.com
Genetic studies in late-onset Alzheimer disease (LOAD) are aimed at identifying core disease mechanisms and providing potential biomarkers and drug candidates to improve …
C Gaiteri, S Mostafavi, CJ Honey… - Nature Reviews …, 2016 - go.gale.com
Genetic studies in late-onset Alzheimer disease (LOAD) are aimed at identifying core disease mechanisms and providing potential biomarkers and drug candidates to improve …
C Gaiteri, S Mostafavi, CJ Honey, PL De Jager… - 2016 - honeylab.org
Genetic studies in late-onset Alzheimer disease (LOAD) are aimed at identifying core disease mechanisms and providing potential biomarkers and drug candidates to improve …